Delivery Order SPE2DB24D2216-SPE2DB25FGPGR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,501.51 to AmerisourceBergen Drug Corp for Gvoke HypoPen auto-injectors (1 mg/0.2 mL, 2-pack). This competitive award, issued on July 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating open competition among eligible...
- The Defense Logistics Agency awarded a $309.83 delivery order to Amerisourcebergen Drug Corporation for 4561920687 Gvoke Hypopen 2-PK 1 MG/0.2 ML 0.2ML. The firm fixed price order is being fulfilled under an existing DLA contract vehicle and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 24, 2023. As a top supplier to the Department of Defense, Amerisourcebergen will deliver these medical supplies to support DLA's...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,670 to Amerisourcebergen Drug Corporation for 4561865431 GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 18-21, 2023. As a prime contractor supporting DLA Troop Support Medical's supply of pharmaceutical products to the Department...
- This is a $1,309.35 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceuticals, with a period of performance through January 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and medical supplies to U.S. government agencies, primarily the...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $2,058.16 to supply Gvoke Hypopen 2-pack 1 mg/0.2 mL syringes. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical product to support DLA's provision of medications and critical care supplies for military treatment facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,960.12, is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medication used for the treatment of hypoglycemia. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a $8,748 delivery order to Amerisourcebergen Drug Corporation for 4561970106 Gvoke Hypopen 2-pk 1 mg/0.2 ml prefilled syringes. The firm fixed price order is to be performed in Conshohocken, Pennsylvania by Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, starting August 28th and concluding August 29th, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring necessary medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $37,434.01 firm-fixed-price contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range...
- The Defense Logistics Agency Troop Support Medical awarded a $309.83 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561431388 GVOKE HYPOPEN 2-PK 1 MG/0.2 ML prefilled syringes. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price arrangement from July 7-10, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Drug Corp will deliver these emergency injection devices to support the Defense Logistics...
- The Defense Logistics Agency awarded a $1,239 delivery order to Amerisourcebergen Drug Corporation for 4561986504 GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML. The firm fixed price order is to be performed in Conshohocken, Pennsylvania through August 30, 2023. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will support order fulfillment from its corporate division. No subcontractors or set aside designations were specified. The Defense Logistics Agency...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPGRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypopenTM auto-injector units (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $19,036.29. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contract specifies performance at the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical prime vendor vehicle extending through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and healthcare systems, supplying medications, vaccines, and medical devices across multiple therapeutic categories. The GVOKE HypopenTM auto-injectors are emergency glucagon delivery devices used for hypoglycemia treatment, reflecting the Defense Health Agency's ongoing procurement of critical medical supplies to support military personnel and beneficiary healthcare needs. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 7/23/25 |